Acute Effects of L-Theanine and L-Tyrosine on Cognitive and Archery Performance (THEA-TYR)
Acute Effects of L-Theanine, L-Tyrosine, and Combined Supplementation on Cognitive and Archery Performance: A Randomized, Placebo-Controlled Crossover Study
This study aims to investigate the acute effects of L-theanine, L-tyrosine, and their combination on cognitive performance and archery performance in trained archers. The study will use a randomized, placebo-controlled, five-condition crossover design involving 21 healthy male archers aged 18 years or older.
Participants will complete five experimental conditions: placebo, L-theanine supplementation (6 mg/kg), L-tyrosine supplementation (50 mg/kg), combined L-theanine and L-tyrosine supplementation, and a no-supplement control condition. Supplements will be administered 60 minutes before performance assessments, with at least 72 hours between experimental sessions.
Cognitive performance will be assessed using the Stroop Test, while archery performance will be evaluated through indoor target shooting at 18 meters. Mood states and perceived exertion will also be assessed using the BRUMS questionnaire and Borg CR-10 scale, respectively.
The study will examine whether these supplementation conditions produce different acute responses in cognitive function and archery performance.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- 1. Being 18 years of age or older. 2. Being a healthy male individual. 3. Having at least five years of regular archery experience. 4. Training in archery at least three days per week. 5. Having national or international competition experience in archery. 6. Voluntarily agreeing to participate in the study.
Exclusion Criteria:
-
1. Having a medical condition that may interfere with participation in the study.
2. Having a known allergy or hypersensitivity to L-theanine or L-tyrosine. 3. Using medications or supplements that may affect cognitive or physical performance during the study period.
4. Being unable to complete all five experimental sessions. 5. Failing to comply with the study procedures.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 기초 과학
- 할당: 무작위
- 중재 모델: 크로스오버 할당
- 마스킹: 없음(오픈 라벨)
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: Five-Condition Crossover Group
All participants will complete five experimental conditions in a randomized crossover design: placebo, L-theanine, L-tyrosine, combined L-theanine and L-tyrosine, and no-supplement control. Each participant will receive all five conditions, with at least 72 hours of washout between sessions. |
Participants will receive a placebo 60 minutes before performance assessments. The placebo will be prepared in a form identical to the active supplementation capsules to maintain blinding. Participants will receive L-theanine at a dose of 6 mg/kg body weight, administered 60 minutes before performance assessments. Participants will receive L-tyrosine at a dose of 50 mg/kg body weight, administered 60 minutes before performance assessments. Participants will receive a combination of L-theanine (6 mg/kg body weight) and L-tyrosine (50 mg/kg body weight), administered together 60 minutes before performance assessments. Participants will complete the performance assessments without receiving any supplementation during this condition. This condition will serve as the no-supplement control for comparison with the placebo and active supplementation conditions. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Total Archery Shooting Score
기간: Immediately after the archery shooting task in each experimental session (approximately 60 minutes after supplement or placebo administration).
|
Archery performance will be assessed by recording the total score obtained from 15 arrows (5 sets of 3 arrows) shot at an indoor target from a distance of 18 meters using a 40-cm target face. Higher scores indicate better archery performance. |
Immediately after the archery shooting task in each experimental session (approximately 60 minutes after supplement or placebo administration).
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
기타 연구 ID 번호
- INU-ARCH-2026-01
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .